Molecular Design of delta-Selective Morphine Dimer Based on Enkephalin Conformation

基于脑啡肽构象的δ选择性吗啡二聚体的分子设计

基本信息

  • 批准号:
    63571029
  • 负责人:
  • 金额:
    $ 1.28万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1988
  • 资助国家:
    日本
  • 起止时间:
    1988 至 1989
  • 项目状态:
    已结题

项目摘要

1. Chemical Syntheses of a Series of Morphine DimersBased on the possible relationship between the molecular conformations of enkephalin and the binding to mu/delta-opioid receptor, an attempt io structurally convert the mu-selective morphine molecule toward delta-selectivity was carried out by a series of morphine dimerizations. A series of morphine dimers in which the nitrogen atoms of two morphine molecules are linked by the -(CH_2)_n- [n= 0 - 6] linkage were chemically synthesized, and their physicochemical properties were elucidated by the spectroscopic method such as ^1H-NMR.2. Pharmacological Measurements of a Series of Morphine DimersPharmacologic activities of a series of morphine dimers were evaluated for the inhibitory effect on contraction of mouse isolated vas deferens and for the binding assay in homogenates of rat brain. The morphine dimer of n=2 exhibited the agonist activity showing about 15 timer more delta-selectivity than the parent morphine molecule, while that of n=3 showed a noticeable antagonist activity for mu/delta-receptor. The dimers of n 4 showed no significant pharmacological activities. The preference of n=2 dimer toward delta-receptor binding and the pharmacological difference between dimers of n=2 and 3 is an important information for considering the substrate specificity of mu/delta-opioid receptor.3. Relationship between the Stable Conformations of Morphine Dimers of n=3 and 3 and the Binding to delta-opioid ReceptorThe energetically stable conformations of morphine dimers of n=2 and 3 were investigated by the quantum chemical MNDO method. As a result, it was suggested as the most stable con- formations the extended planar form for n=2 dimer in which two morphine chromophores are almost related to each other with a C2-symmetry and the folded form without showing C2-symm- etry for n=3 dimer. This result clearly shows the preference of extended C2-symmetric conformation of opioid for the binding with delta-receptor.
1.一系列吗啡二聚体的化学合成基于脑啡肽分子构象与μ/δ-阿片受体结合之间可能存在的关系,尝试通过一系列吗啡二聚化将μ-选择性吗啡分子结构转变为δ-选择性。化学合成了一系列吗啡二聚体,其中两个吗啡分子的氮原子通过-(CH_2)_n-[n=0-6]键连接,并通过^1H-NMR等波谱方法阐明了它们的理化性质。2.一系列吗啡二聚体的药理学测量评估了一系列吗啡二聚体的药理学活性,以评价其对小鼠离体输精管收缩的抑制作用以及在大鼠脑匀浆中的结合测定。 n=2的吗啡二聚体显示出比母体吗啡分子高约15倍的δ选择性的激动剂活性,而n=3的吗啡二聚体显示出对mu/δ受体的显着拮抗活性。 n 4 的二聚体没有表现出显着的药理活性。 n=2二聚体对δ-受体结合的偏好以及n=2和3二聚体之间的药理学差异是考虑mu/delta-阿片受体底物特异性的重要信息。 3. n=3和3的吗啡二聚体的稳定构象与δ-阿片受体结合的关系通过量子化学MNDO方法研究了n=2和3的吗啡二聚体的能量稳定构象。因此,n=2 二聚体的扩展平面形式被认为是最稳定的构象,其中两个吗啡发色团几乎以 C2 对称性彼此相关,而 n=3 二聚体的折叠形式则不显示 C2 对称性。该结果清楚地表明阿片类药物的扩展 C2 对称构象更倾向于与 δ 受体结合。

项目成果

期刊论文数量(22)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
屋良肇: "An attempt for structurally convert mu-selective morphine towad delta-receptor binding:Dimerization based on enkephalin conformation." Eur.J.Pharmacol.(1990)
Hajime Yara:“将 mu 选择性吗啡结构转化为 δ 受体结合的尝试:基于脑啡肽构象的二聚化。”(1990)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
S.Yoneda, K.Kitamura, M.Doi, M.Inoue and T.Ishida: "Importance of folded monomer and extended antiparallel dimer structures as enkephalin active conformation: Molecular-dynamics simulations of [Met^5]enkephalin in water" FEBS Lett. 239, 271-275 (1988).
S.Yoneda、K.Kitamura、M.Doi、M.Inoue 和 T.Ishida:“折叠单体和扩展反平行二聚体结构作为脑啡肽活性构象的重要性:水中 [Met^5] 脑啡肽的分子动力学模拟” FEBS
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T.Ishida and M.Doi: "Substrate specificity of mu/delta- opioid receptor based on enkephalin conformation" Biophysics.
T.Ishida 和 M.Doi:“基于脑啡肽构象的 mu/δ-阿片受体的底物特异性”生物物理学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
石田寿昌: "Molecular-dynamics simulations of(Met^5)-and(D-Ala^2,Met^5)-enkephalins:Biological implications of monomeric folded and dimeric unfolded conformations" Biochem.J.255. 621-628 (1988)
Toshimasa Ishida:“(Met^5)-和(D-Ala^2,Met^5)-脑啡肽的分子动力学模拟:单体折叠和二聚体未折叠构象的生物学意义”Biochem.J.255( 1988)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
屋良肇: "An attempt for structurally convert mu-selective morphine toward delta-receptor binding:Dimerization based on enkephalin conformation." Eur.J.Pharmacol.(1990)
Hajime Yara:“尝试在结构上将 mu 选择性吗啡转化为 δ 受体结合:基于脑啡肽构象的二聚化。”(1990)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ISHIDA Toshimasa其他文献

ISHIDA Toshimasa的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ISHIDA Toshimasa', 18)}}的其他基金

Non-adiabatic reaction dynamics simulation of biomolecules responding to photons
生物分子响应光子的非绝热反应动力学模拟
  • 批准号:
    20608003
  • 财政年份:
    2008
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of the inhibitor for tangle formation of tau protein : Basic research for prevention of Altzheimer disease
tau蛋白缠结形成抑制剂的开发:预防阿尔茨海默病的基础研究
  • 批准号:
    20590111
  • 财政年份:
    2008
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of generation of large-male potential energy surfaces num local interpolation and molecular mechanics
大雄势能面num局部插值和分子力学生成的发展
  • 批准号:
    16550025
  • 财政年份:
    2004
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidatiop of Tangle Formation Mechanism Based on 3D-structural Analysis of Tau Protein
基于 Tau 蛋白 3D 结构分析阐明缠结形成机制
  • 批准号:
    13680752
  • 财政年份:
    2001
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development and applications of an interpolation scheme of potential energy surfaces which can be combined with latest ab initio methodologies
可与最新的从头计算方法相结合的势能面插值方案的开发和应用
  • 批准号:
    12640492
  • 财政年份:
    2000
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular design of cathepsin L-specific inhibitor based on the teritiary structure.
基于三级结构的组织蛋白酶L特异性抑制剂的分子设计。
  • 批准号:
    06453194
  • 财政年份:
    1994
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Expression of mRNA cap-binding protein and structure analysis of its cap recognition mechanism
帽结合蛋白mRNA的表达及其帽识别机制的结构分析
  • 批准号:
    02453146
  • 财政年份:
    1990
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

Targeting the allosteric sodium site with novel probes for delta opioid receptor
用新型 δ 阿片受体探针靶向变构钠位点
  • 批准号:
    10892532
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
Exploring the Applicability of Potential Negative Allosteric Modulators at the Mu Opioid Receptor
探索 Mu 阿片受体潜在负变构调节剂的适用性
  • 批准号:
    10607645
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
Methocinnamox (MCAM): A novel opioid receptor antagonist
Methocinnamox (MCAM):一种新型阿片受体拮抗剂
  • 批准号:
    10844948
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
Deciphering biased agonistic activation of mu-opioid receptor by novel optogenetic hydrogen peroxide sensor
新型光遗传学过氧化氢传感器破译μ阿片受体的偏向激动激活
  • 批准号:
    10604662
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
Investigating the Mu:Kappa Opioid Receptor Imbalance in Alcohol Use Disorder
研究酒精使用障碍中的 Mu:Kappa 阿片受体失衡
  • 批准号:
    10731950
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
G alpha Z subunit as a potential therapeutic target to modulate mu opioid receptor pharmacology
G α Z 亚基作为调节 mu 阿片受体药理学的潜在治疗靶点
  • 批准号:
    10580415
  • 财政年份:
    2022
  • 资助金额:
    $ 1.28万
  • 项目类别:
Development of Specific Mu Opioid Receptor Antagonists to Reverse the Acute and Chronic Toxicity of Fentanyls
开发特异性 Mu 阿片受体拮抗剂以逆转芬太尼的急性和慢性毒性
  • 批准号:
    10476705
  • 财政年份:
    2022
  • 资助金额:
    $ 1.28万
  • 项目类别:
Spatiotemporal signaling and trafficking of the mu-opioid receptor
mu-阿片受体的时空信号传导和运输
  • 批准号:
    10895814
  • 财政年份:
    2022
  • 资助金额:
    $ 1.28万
  • 项目类别:
The effect of biased agonism at the Mu-Opioid receptor on drug seeking behavior
Mu-阿片受体的偏向激动对药物寻求行为的影响
  • 批准号:
    10590603
  • 财政年份:
    2022
  • 资助金额:
    $ 1.28万
  • 项目类别:
Elucidating the Proximal Interactome Networks of the Mu-Opioid Receptor to Delineate its Functional Selectivity
阐明 Mu-阿片受体的近端相互作用组网络以描述其功能选择性
  • 批准号:
    559774-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Doctoral
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了